Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
Inflammatory bowel disease (IBD) affects approximately 1.6 million people in the U.S. According to a report in Healio, this equates to about 1.3% of the adult population. IBD can be…
Continue ReadingInflammatory bowel disease (IBD) affects approximately 1.3% of the U.S. adult population
A presenter at the COPD 2024 International Conference spoke about the ease with which heart failure and preserved ejection factor (HfpE) is misdiagnosed in COPD patients due to the similarity…
Sixty-six-year-old Tim Andrews, a resident of New Hampshire, is the fourth patient worldwide to undergo a pig kidney transplantation. As reported recently in a Mass General News Release, Tim is…
Continue ReadingThe Second Successful Genetically Edited Pig Transplant Performed by Harvard Surgeons at Mass General
As reported in a recent edition of the Harvard Gazette, AI is commonly used to analyze X-rays and scans. AI has begun to outperform physicians in prognostic and diagnostic assessments.…
Continue ReadingShould AI Make Diagnostic and Prognostic Assessments for End-of-Life Decisions?
In June 2023 Jenny Decker took time out from her job as a trauma nurse and sailed out of Kona, Hawaii, beginning her solo voyage around the globe. Jenny’s mission…
Continue ReadingNurse JENNY DECKER is Sailing Around the Globe to Raise Awareness for Charcot-Marie-Tooth Disease – UPDATE
This article is written by Enrico Orzes and originally published on Osservatorio Malattie Rare (OMaR). It has been translated from Italian. Patient Worthy is grateful to the team at OMaR…
Continue ReadingThe story of Laura and Martina and a rare disease called GACI with two very different outcomes.
Mesoblast Biotechnology Company has received FDA approval for its Ryoncil therapy as the first of its kind to be approved in the United States. The therapy has been developed to…
Continue ReadingFDA Approves the first Mesenchymal Stromal Cell Therapy to Treat the Graft Versus Host Disease in Adults and Children
Sickle Cell, an inherited disease, involves crescent shaped red blood cells that are the “vehicles” containing hemoglobin, a protein responsible for carrying oxygen throughout the body. For almost a year…
Continue ReadingSickle Cell Disease: Two Drugs are An Arm’s Length from a Potential Cure
Roche has been developing an experimental drug for Parkinson’s disease for over ten years. According to BioPharma Dive, the latest statements from the company are that the drug, prasinezumab, failed…
Continue ReadingParkinson’s: Roche Will Continue Activity with Prasinezumab After Second Failure
According to the data that was presented at the 2024 ACR Convergence, a considerable number of patients are hospitalized when it could have been avoided. As reported in Healio News,…
Continue ReadingRheumatoid Arthritis Patients Can Avoid Hospitalization by Seeking Early Treatment
Approximately one and one half million people are affected by ulcerative colitis (UC) worldwide. It is an inflammatory bowel disorder with, as of yet, no known cause. There are, however,…
Continue ReadingUlcerative Colitis: Over One Million People are Waiting for Dosing to Begin in First-in Human Trial
The FDA’s recent approval of AbbVie’s new combination therapy provides patients with longer-lasting control of movements. As described recently in Biopharmadive, Parkinson’s disease is characterized by uncontrolled muscle movements or…
Continue ReadingParkinson’s: Newly Approved Drug Gives Advanced-Stage Patients Longer Periods of Relief
The use of the gene therapy elivaldogene autotemcel (Skysona), has been approved due to its success in the treatment of patients diagnosed with the neurological disease cerebral adrenoleukodystrophy (CALD). The…
Continue ReadingGene Therapy Promising for Cerebral Adrenoleukodystrophy but Carries Risk of Blood Cancer
According to a recent report in Healio News, the GLP-1 agonists are medications developed primarily to control blood sugar levels for type two diabetes. About the FLOW Clinical Trial The…
Continue ReadingThe Newest Medications to Treat Chronic Kidney Disease in Type Two Diabetes
Spinal muscular atrophy (SMA) is a rare disease causing progressive muscular weakness. Severe forms of the disease can be fatal to infants. Apitegromab is an experimental therapy that was successful…
Continue ReadingPositive Trial Data is Welcomed News for Spinal Muscular Atrophy Patients
Eighty-five-year-old Frank Meuers considers his 500th immunoglobulin infusion to be a cause for celebration. Frank has logged details of his doctor’s visits since his first dose of replacement therapy with…
Continue ReadingIt Took Almost 60 Years for the Correct Diagnosis and Treatment for Primary Immunodeficiency
The Riken Center team, headed by Dr. Takaomi Saido and using mice with Alzheimer’s, discovered that dopamine may lessen the brain’s physical symptoms and improve memory. The study, featured in…
Continue ReadingAlzheimer’s: Researchers at Japan’s Riken Center Discover a New Treatment to Alleviate Symptoms and Improve Memory
Fredericksburg, Virginia resident Johnny Boatman is a former national guardsman who had been in excellent physical condition all his life. That was until 2022 when he felt a sharp pain…
Continue Reading‘Anyone with a Heart’ Campaign Spreads Awareness About Hereditary ATTR Amyloidosis
It has been almost a decade since the European medical community welcomed news of an innovation for primary biliary cholangitis (PBC). Therefore, the EC’s recent conditional approval of Ipsen’s drug…
Continue ReadingNew Drug Approved in the EU to Treat Primary Biliary Cholangitis
In 2023 a 19-year-old male teenager was suffering from memory decline that first began when he was 17 years of age. His cognitive losses continued during the next few years.…
A protein called Aplp1 is now on the radar for its ability to spread material in the brain that may be responsible for Parkinson’s disease. Another protein, Lag3, interacts with…
Continue ReadingCould This Cancer Drug Play a Role in Parkinson’s Treatment?
Researchers discovered a version of the Cas protein that fits into adeno-associated viruses (AAVs). This virus can be engineered to deliver targeted therapy to cells and is a common approach…
Continue ReadingDiscovery of More Compact Cas Protein Heralds Progress for Gene Therapy
Almost 100,000 people in the United States have been diagnosed with sickle cell disease (SCD). About one million people worldwide have the disease. Patients are at risk of death in…
Continue ReadingCured of Sickle Cell Disease, His Next Challenge was Mt. Kilimanjaro
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Sign Up For Our Patient Panel
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.